{ "cik": 917520, "cik_padded": "0000917520", "entityName": "INTEGRA LIFESCIENCES HOLDINGS CORP", "fiscal_years": [ { "accn": "0000917520-26-000011", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 221000.0, "capex": 81436000.0, "cash": 235048000.0, "eps_diluted": -6.74, "free_cash_flow": -31052000.0, "net_income": -516474000.0, "operating_cash_flow": 50384000.0, "operating_income": -493370000.0, "revenue": 1635245000.0, "stockholders_equity": 1043463000.0, "total_assets": 3602001000.0, "total_liabilities": 2558538000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.4519681100336093, "net_margin": -0.31583891098887323, "operating_margin": -0.30171014129381224, "revenue_growth_yoy": 0.015347771257482799, "roa_avg2y": -0.1352127941566283, "roa_period_end": -0.14338530166982186, "roe_avg2y": -0.39901527498094636, "roe_period_end": -0.49496148881177393 } }, { "accn": "0000917520-26-000011", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 52471000.0, "capex": 104418000.0, "cash": 246375000.0, "eps_diluted": -0.09, "free_cash_flow": 24964000.0, "net_income": -6944000.0, "operating_cash_flow": 129382000.0, "operating_income": 28411000.0, "revenue": 1610527000.0, "stockholders_equity": 1545280000.0, "total_assets": 4037424000.0, "total_liabilities": 2492144000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.6127459101263202, "net_margin": -0.004311632155188954, "operating_margin": 0.0176408094990025, "revenue_growth_yoy": 0.0447296365465664, "roa_avg2y": -0.0017760926269136349, "roa_period_end": -0.0017199085357396198, "roe_avg2y": -0.004432579973470907, "roe_period_end": -0.00449368399254504 } }, { "accn": "0000917520-26-000011", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 275000000.0, "capex": 66865000.0, "cash": 276402000.0, "eps_diluted": 0.84, "free_cash_flow": 73090000.0, "net_income": 67741000.0, "operating_cash_flow": 139955000.0, "operating_income": 111526000.0, "revenue": 1541573000.0, "stockholders_equity": 1587884000.0, "total_assets": 3781988000.0, "total_liabilities": 2194104000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.3817785178262392, "net_margin": 0.043942777928777946, "operating_margin": 0.07234558467227954, "revenue_growth_yoy": -0.010331483129245936, "roa_avg2y": 0.01765986517280421, "roa_period_end": 0.017911479359532606, "roe_avg2y": 0.03993824814940481, "roe_period_end": 0.04266117676102285 } }, { "accn": "0000917520-26-000011", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 125000000.0, "capex": 42343000.0, "cash": 456661000.0, "eps_diluted": 2.16, "free_cash_flow": 222126000.0, "net_income": 180550000.0, "operating_cash_flow": 264469000.0, "operating_income": 238920000.0, "revenue": 1557666000.0, "stockholders_equity": 1804403000.0, "total_assets": 3889758000.0, "total_liabilities": 2085355000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.15570357619667, "net_margin": 0.11591059957654594, "operating_margin": 0.15338333121477904, "revenue_growth_yoy": 0.009866134871321432, "roa_avg2y": 0.047066392549354866, "roa_period_end": 0.046416769372284866, "roe_avg2y": 0.10349056390176908, "roe_period_end": 0.10006079573133053 } }, { "accn": "0000917520-25-000017", "filed": "2025-02-25", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 48022000.0, "cash": 513448000.0, "eps_diluted": 1.98, "free_cash_flow": 264405000.0, "net_income": 169075000.0, "operating_cash_flow": 312427000.0, "operating_income": 197230000.0, "revenue": 1542448000.0, "stockholders_equity": 1684804000.0, "total_assets": 3782383000.0, "total_liabilities": 2097579000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.2449988247891148, "net_margin": 0.10961471634700165, "operating_margin": 0.12786816800307044, "revenue_growth_yoy": 0.12434140894021874, "roa_avg2y": 0.04571127157632174, "roa_period_end": 0.04470065564486727, "roe_avg2y": 0.10568274050675835, "roe_period_end": 0.10035291939002994 } }, { "accn": "0000917520-24-000022", "filed": "2024-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 100000000.0, "capex": 38890000.0, "cash": 470166000.0, "eps_diluted": 1.57, "free_cash_flow": 164942000.0, "net_income": 133892000.0, "operating_cash_flow": 203832000.0, "operating_income": 151370000.0, "revenue": 1371868000.0, "stockholders_equity": 1514867000.0, "total_assets": 3615136000.0, "total_liabilities": 2100269000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.3864378853061028, "net_margin": 0.09759831120778382, "operating_margin": 0.1103386040056332, "revenue_growth_yoy": -0.0960023247891183, "roa_avg2y": 0.03870619347661937, "roa_period_end": 0.03703650429748701, "roe_avg2y": 0.09134388251069465, "roe_period_end": 0.08838531699482528 } }, { "accn": "0000917520-23-000015", "filed": "2023-02-22", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 69537000.0, "cash": 198911000.0, "eps_diluted": 0.58, "free_cash_flow": 161896000.0, "net_income": 50201000.0, "operating_cash_flow": 231433000.0, "operating_income": 93760000.0, "revenue": 1517557000.0, "stockholders_equity": 1416736000.0, "total_assets": 3303240000.0, "total_liabilities": 1886504000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.3315847130305152, "net_margin": 0.03308014130605967, "operating_margin": 0.061783511261850464, "revenue_growth_yoy": 0.03064027692790407, "roa_avg2y": 0.015660585104615772, "roa_period_end": 0.01519750305760405, "roe_avg2y": 0.035953750932845176, "roe_period_end": 0.03543426580534412 } }, { "accn": "0000917520-22-000010", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 77741000.0, "cash": 138838000.0, "eps_diluted": 0.72, "free_cash_flow": 121942000.0, "net_income": 60801000.0, "operating_cash_flow": 199683000.0, "operating_income": 110998000.0, "revenue": 1472441000.0, "stockholders_equity": 1375796000.0, "total_assets": 3107887000.0, "total_liabilities": 1732091000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.2589737141262223, "net_margin": 0.041292656208296294, "operating_margin": 0.07538366562734941, "revenue_growth_yoy": 0.23918228365408892, "roa_avg2y": 0.01924342917331841, "roa_period_end": 0.01956345259657124, "roe_avg2y": 0.0520088516240951, "roe_period_end": 0.04419332517320882 } }, { "accn": "0000917520-21-000018", "filed": "2021-02-23", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 43503000.0, "cash": 174935000.0, "eps_diluted": 0.82, "free_cash_flow": 71041000.0, "net_income": 64743000.0, "operating_cash_flow": 114544000.0, "operating_income": 44804000.0, "revenue": 1188236000.0, "stockholders_equity": 962306000.0, "total_assets": 3211257000.0, "total_liabilities": 2248951000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.3370435183818867, "net_margin": 0.05448665080000943, "operating_margin": 0.03770631423387273, "revenue_growth_yoy": 0.19772799435526547, "roa_avg2y": 0.02579807862231733, "roa_period_end": 0.020161263953648055, "roe_avg2y": 0.07185790242140143, "roe_period_end": 0.06727901519890762 } }, { "accn": "0000917520-20-000010", "filed": "2020-02-21", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 47328000.0, "cash": 102055000.0, "eps_diluted": 0.94, "free_cash_flow": 69077000.0, "net_income": 74564000.0, "operating_cash_flow": 116405000.0, "operating_income": 115340000.0, "revenue": 992075000.0, "stockholders_equity": 839667000.0, "total_assets": 1807954000.0, "total_liabilities": 968287000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1531797724574147, "net_margin": 0.07515964014817428, "operating_margin": 0.11626137136809213, "roa_period_end": 0.04124219974623248, "roe_period_end": 0.08880187026523609 } }, { "accn": "0000917520-14-000007", "filed": "2014-02-27", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "buybacks": "USD" }, "fundamentals": { "buybacks": 0.0 }, "period_end": "2013-12-31", "ratios": {} }, { "accn": "0000917520-14-000007", "filed": "2014-02-27", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "buybacks": "USD" }, "fundamentals": { "buybacks": 0.0 }, "period_end": "2012-12-31", "ratios": {} } ], "latest_filing": { "accn": "0000917520-26-000011", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3841", "sic_description": "Surgical & Medical Instruments & Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000917520.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000917520.json" }, "ticker": "IART" }